News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Vision Restored: The Latest Technologies to Improve Sight
Anna Azvolinsky | Apr 10, 2018
Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.
Gene Therapy for Age-Related Macular Degeneration Safe in Humans
Diana Kwon | May 17, 2017
A small Phase 1 clinical trial reports that, even at high doses, the treatment did not lead to adverse reactions.
Women Lose Vision After Stem Cell Treatment
Kerry Grens | Mar 17, 2017
The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration.
Regulators OK Clinical Trials Using Donor Stem Cells
Kerry Grens | Feb 6, 2017
Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.
Toward Preventing Transplant Rejection with Immunologically Matched Stem Cells
Ruth Williams | Sep 15, 2016
Matching the immunological characteristics of donor retinal cells to those of the recipient can reduce the chance of rejection.
Bionic Eye Success
Jef Akst | Jul 23, 2015
An 80-year-old man with age-related vision loss receives a retinal implant that allows him to see basic shapes.
Eye Stem Cell Therapy Moves Ahead
Kate Yandell | Apr 30, 2015
Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety.
Stimulating Neurons with Light and Gold
Jef Akst | Mar 12, 2015
Researchers develop a technique to trigger neural activity in culture using light to heat gold nanoparticles.
Week in Review: March 24–28
Tracy Vence | Mar 28, 2014
Synthetic yeast chromosome; human enhancers and promoters mapped; brain-wide map links fly behaviors to neurons; treating eye diseases with nanotechnology
An Eye for Stem Cells
Hannah Waters | Dec 1, 2011
Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.